Systemic lupus erythematosus: year in review 2019.

Area of Science:

• Rheumatology
• Immunology
• Internal Medicine

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune condition with diverse clinical presentations.
• Significant challenges and unanswered questions persist in understanding and managing SLE.
• 2019 marked a period of substantial progress in SLE research and clinical practice.

Purpose of the Study:

• To review high-quality studies published in 2019 concerning SLE.
• To provide insights into SLE pathogenesis, clinical manifestations, and prognosis.
• To summarize therapeutic advances and updated recommendations for SLE management.

Main Methods:

• Comprehensive literature search of notable SLE studies from 2019.
• Focus on clinical and basic research advancements.
• Synthesis of data on pathogenesis, diagnosis, prognosis, and treatment.

Main Results:

• Updated classification criteria and management recommendations for SLE were established.
• New therapeutic agents for SLE demonstrated promise in development and testing.
• Novel insights into SLE pathogenesis and disease prognosis emerged from recent research.

Conclusions:

• The review consolidates key 2019 findings to guide future SLE research and clinical practice.
• Ongoing clinical studies are essential to validate new SLE treatments.
• Continued exploration is vital to address the heterogeneity and challenges of SLE.